Contract Research Organizations (CROs) in China
Integrating Chinese research and development capabilities for global drug innovation
Bibliographic Data
| ID | 19534286 |
|---|---|
| Authors | Yun-Zhen Shi, Yunzhen Shi (University of Macau), Hao Hu (0000-0003-1365-0267, University of Macau, corresponding author), Chunming Wang (0000-0001-9185-9678, University of Macau) |
| Year | 2014 |
| Volume | 10 |
| Issue | 1 |
| Pages | 78-78 |
| Publication date | 2014-12-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Globalization and Health (JOURNAL) |
| Journal identifiers | ISSN: 1744-8603 • E-ISSN: 1744-8603 |
| Publisher | Springer Science and Business Media LLC (PUBLISHER) |
| DOI | 10.1186/s12992-014-0078-4 |
| PMID | 25406839 |
| PMCID | PMC4240890 |
| OpenAlex | W2154567401 |
| Language | EN |
| Citations received | 4 |
| References cited | 19 |
The significance of R&D capabilities of China has become increasingly important as an emerging force in the context of globalization of pharmaceutical research and development (R&D). While China has prospered in its R&D capability in the past decade, how to integrate the rising pharmaceutical R&D capability of China into the global development chain for innovative drugs remains challenging. For many multinational corporations and research organizations overseas, their attempt to integrate China's pharmaceutical R&D capabilities into their own is always hindered by policy constraints and reluctance of local universities and pharmaceutical firms. In light of the situation, contract research organizations (CROs) in China have made great innovation in value proposition, value chain and value networking to be at a unique position to facilitate global and local R&D integration. Chinese CROs are now being considered as the essentially important and highly versatile integrator of local R&D capability for global drug discovery and innovation
Business · China · Comparative advantage · Economics · Global value chain · Globalization · Industrial organization · International trade · Market economy · Multinational corporation · Pharmaceutical industry · Political science · Biotechnology and Related Fields · Computer Science · Intellectual Property and Patents · Law · Pharmaceutical Economics and Policy · Biotechnology · Finance
How does organizational support for creativity affect research and development (R&D) employees’ innovative behavior
Does Innovation Mediate the Relationship Between ICT Use and Competitive Advantage? Investigating the Perceptions of Practitioners in the Pharmaceutical Industry
Outsourcing of research and development and efficiency
Creating Knowledge Assets under Biocapitalism
| Citations per year | 1 |
|---|---|
| Citation span | 2022 - 2025 (4) |
| Highly cited | No |